» Articles » PMID: 31001472

Performance of Different Combination Models of High-Risk HPV Genotyping in Triaging Chinese Women With Atypical Squamous Cells of Undetermined Significance

Overview
Journal Front Oncol
Specialty Oncology
Date 2019 Apr 20
PMID 31001472
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

The purpose of this study was to evaluate the effect of different combination models of high-risk human papilloma viruses (HPV) genotyping in triaging Chinese women with atypical squamous cells of undetermined significance (ASCUS). We established a screening cohort of 3,997 Chinese women who underwent cervical cytology and HPV genotyping test. Women with ASCUS cytology underwent punch biopsy under colposcopy/endocervical curettage. The sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) of different combination models of HR-HPV genotyping calculated that cervical intraepithelial neoplasia 2 or higher (CIN2+) on histology were endpoints. Of the full sample, 393 women had ASCUS. Among ASCUS women with a CIN2 lesion, the prevalence for HPV were 40.0% (type 16), 10.0% (type 18), 0.0% (type 33), 30.0% (type 52), 40.0% (type 58), and 30.0% (other nine types). For ASCUS women with a CIN3 lesion, the prevalence for HPV were 68.4% (type 16), 15.8% (type 18), 10.5% (type 33), 31.6% (type 52), 15.8% (type 58), and 36.8% (other nine types). Combination model including HPV16/18/33/52/58 for predicting CIN2+ lesion in women with ASCUS had relatively higher sensitivity [93.1% (78.0, 98.1)], specificity [75.8% (71.2, 79.9)], PPV [23.5% (16.7, 32.0)], and NPV [99.3% (97.4, 99.8)] than other combination models. Moreover, the referral rate of HPV16/18/33/52/58 (29.3%) was lower than HR-HPV (36.1%). The study demonstrates that specific HR-HPV types HPV16/18/33/52/58 may be an effective strategy in ASCUS triage. This improves the subsequent selection of ASCUS patients.

Citing Articles

Comparative study of triage strategies for women with atypical squamous cells of undetermined significance in the post-vaccine era.

Yang H, Hao Y, Niu M, Zheng J, Jia X, Zhang S Front Oncol. 2024; 14:1416116.

PMID: 39439955 PMC: 11494462. DOI: 10.3389/fonc.2024.1416116.


Analysis of the related factors of atypical squamous cells of undetermined significance (ASC-US) in cervical cytology of post-menopausal women.

Li B, Dong L, Wang C, Li J, Zhao X, Dong M Front Cell Infect Microbiol. 2023; 13:1123260.

PMID: 36875525 PMC: 9978476. DOI: 10.3389/fcimb.2023.1123260.


Efficient combination of Human Papillomavirus Genotyping for the triage of women with Atypical Squamous Cells of Undetermined Significance in Chinese rural population: A population-based study.

Wang W, Zhang H, Lin L, Yang A, Yang J, Zhao W J Cancer. 2021; 12(10):2815-2824.

PMID: 33854582 PMC: 8040879. DOI: 10.7150/jca.55771.


The Triage Effectiveness of an Extended High-Risk Human Papillomavirus Genotyping Assay for Women with Cytology Showing Atypical Squamous Cells of Undetermined Significance in China.

Pan D, Dong B, Gao H, Mao X, Xue H, Sun P Risk Manag Healthc Policy. 2020; 13:1747-1756.

PMID: 33061708 PMC: 7522426. DOI: 10.2147/RMHP.S270265.

References
1.
Nobbenhuis M, Walboomers J, Helmerhorst T, Rozendaal L, Remmink A, Risse E . Relation of human papillomavirus status to cervical lesions and consequences for cervical-cancer screening: a prospective study. Lancet. 1999; 354(9172):20-5. DOI: 10.1016/S0140-6736(98)12490-X. View

2.
Schlecht N, Kulaga S, Robitaille J, Ferreira S, Santos M, Miyamura R . Persistent human papillomavirus infection as a predictor of cervical intraepithelial neoplasia. JAMA. 2002; 286(24):3106-14. DOI: 10.1001/jama.286.24.3106. View

3.
Solomon D, Davey D, Kurman R, Moriarty A, OConnor D, Prey M . The 2001 Bethesda System: terminology for reporting results of cervical cytology. JAMA. 2002; 287(16):2114-9. DOI: 10.1001/jama.287.16.2114. View

4.
Wright Jr T, Cox J, Massad L, Twiggs L, Wilkinson E . 2001 Consensus Guidelines for the management of women with cervical cytological abnormalities. JAMA. 2002; 287(16):2120-9. DOI: 10.1001/jama.287.16.2120. View

5.
Cox J . Management of women with cervical cytology interpreted as ASC-US or as ASC-H. Clin Obstet Gynecol. 2005; 48(1):160-77. DOI: 10.1097/01.grf.0000151571.91814.f3. View